JAMES B BREITMEYER Insider Trading $ZGNX ZOGENIX, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES B BREITMEYER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES B BREITMEYER. JAMES B BREITMEYER is VP PHARMACEUTICAL OPERATIONS in CytoCore, Inc. ($AMEV) and Chief Executive Officer in Oncternal Therapeutics, Inc. ($GTXI) and President, CEO in GTX INC /DE/ ($GTXI) and Director in ZOGENIX, INC. ($ZGNX) and Director in OTONOMY, INC. ($OTIC).
JAMES B BREITMEYER in ZOGENIX, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES B BREITMEYER: Director
Holdings: 6,250 shares
Current Value: $53,125
Latest Transaction: Jun 29 2020
$ZGNX Market Capitalization: $228.07M
$ZGNX Previous Close: $8.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES B BREITMEYER in ZOGENIX, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMEV, ONCT, OTIC, ZGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2020 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 29.13 | 13,000 | 378,690 | 13,000 | |
| Dec 18 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | M | 8.99 | 5,000 | 44,950 | 10,000 | |
| Dec 18 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Sell | S | 50.00 | 5,000 | 250,000 | 1,250 | 6.3 K to 1.3 K (-80.00 %) |
| Dec 18 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Buy | M | 8.99 | 5,000 | 44,950 | 6,250 | 1.3 K to 6.3 K (+400.00 %) |
| Nov 27 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | M | 8.99 | 5,000 | 44,950 | 15,000 | |
| Nov 27 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Sell | S | 50.00 | 5,000 | 250,000 | 1,250 | 6.3 K to 1.3 K (-80.00 %) |
| Nov 27 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Buy | M | 8.99 | 5,000 | 44,950 | 6,250 | 1.3 K to 6.3 K (+400.00 %) |
| May 28 2019 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 39.02 | 13,000 | 507,260 | 13,000 | |
| May 24 2018 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 41.68 | 15,000 | 625,200 | 15,000 | |
| May 23 2017 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 12.75 | 20,000 | 255,000 | 20,000 | |
| Jul 15 2016 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 8.99 | 20,000 | 179,800 | 20,000 | |
| Jun 19 2015 | ZGNX | ZOGENIX, INC. | BREITMEYER JAMES B | Director | Option Exercise | A | 1.60 | 72,000 | 115,200 | 72,000 |
Page: 1